(Q33843858)

29 July 2017

1 reference

title

LH-RH analogues: I. Their impact on reproductive medicine (English)

1 reference

29 July 2017

Schally AV

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Gynecological Endocrinology

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

401-409

1 reference

Isolation and properties of the FSH and LH-releasing hormone

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Structure of the porcine LH- and FSH-releasing hormone. II. Confirmation of the proposed structure by conventional sequential analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Signal transduction mechanisms of Ca2+ mobilizing hormones: the case of gonadotropin-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Gonadotropin-releasing hormone and its analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Inhibition of ovulation in women by chronic treatment with a stimulatory lrh analogue — A new approach to birth control?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167587

Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

FSH-releasing hormone and LH-releasing hormone.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Hypothalamic Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH)-Regulating Hormone: Structure, Physiology, and Clinical Studies**The work described here has been supported by research grants from the Veterans Administration, United State

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Delay of puberty and inhibition of reproductive processes in the rat by a gonadotropin-releasing hormone agonist analog

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Male contraception; synergism of gonadotropin-releasing hormone analog and testosterone in suppressing gonadotropin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Never on a Sunday: programming for IVF-ET and GIFT

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRH

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Induction of ovulation with D-Trp6-LHRH combined with purified FSH in patients with polycystic ovarian disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Anovulatory effect of a LHRH antagonist in women

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Effect of a GnRH analogue (leuprolide) on benign prostatic hypertrophy

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Flare-up of endometriosis induced by gonadotropin-releasing hormone agonist leading to bowel obstruction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.3109/09513599909167587

Identifiers

DOI

10.3109/09513599909167587

1 reference

29 July 2017

1 reference